Table 5. UGT1A genotypes, haplotypes and toxicity.
Haematologic
|
No haematologic
|
Neutropenia
|
Diarrhoea
|
Neutropenia and diarrhoea
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene | Genotype | Yes (%) | OR (95% CI) | P | Yes (%) | OR (95% CI) | P | Yes (%) | OR (95% CI) | P | Yes (%) | OR (95% CI) | P | Yes (%) | OR (95% CI) | P |
First cycle | ||||||||||||||||
UGT1A1 | *28/*28 | 2 (13.3) | 2.14 (0.42–10.86) | 0.31 | 6 (40) | 4.92 (1.55–15.64) | 0.004 | 1 (6.7) | 1.13 (0.13–9.67) | 1 | 4 (26.7) | 3.7 (1.02–13.42) | 0.036 | — | — | — |
Other | 9 (6.7) | 1 | 16 (11.9) | 1 | 8 (6) | 1 | 12 (9) | 1 | — | — | ||||||
UGT1A9 | *1/*1 | 3 (5.3) | 1 | 0.44 | 12 (11.9) | 1 | 0.09 | 2 (3.5) | 1 | 0.5 | 9 (15.8) | 1 | 0.1 | — | — | — |
Other | 8 (8.7) | 1.71 (0.44–6.75) | 10 (21.1) | 0.46 (0.18–1.14) | 7 (7.6) | 2.3 (0.45–11.3) | 7 (7.6) | 0.44 (0.15–1.25) | — | — | ||||||
UGT1A7 | *3/*3 | 2 (9.1) | 1.31 (0.26–6.52) | 0.74 | 4 (10.9) | 1.35 (0.41–4.44) | 0.63 | 8 (4.5) | 0.71 (0.08–5–96) | 1 | 2 (9.1) | 0.81 (0.17–3.83) | 1 | — | — | — |
Other | 9 (7.1) | 1 | 18 (18.2) | 1 | 1 (6.3) | 1 | 14 (11) | 1 | — | — | ||||||
All UGTs | No favourable* | 2 (18.2) | 3.19 (0.6–17) | 0.16 | 4 (36.4) | 3.8 (1.01–14.33) | 0.036 | 1 (9.1) | 1.63 (0.18–14.32) | 0.5 | 2 (18.2) | 1.97 (0.39–10.03) | 0.33 | — | — | — |
Other | 9 (6.5) | 1 | 18 (13) | 1 | 8 (5.8) | 1 | 14 (10.1) | 1 | — | — | ||||||
All UGTs | Favourable | 8 (8.9) | 1 | 0.53 | 9 (10) | 1 | 0.043 | 7 (7.8) | 1 | 0.32 | 6 (6.7) | 1 | 0.047 | — | — | — |
Other | 3 (5.1) | 0.55 (0.14–2.16) | 13 (22) | 2.54 (1.01–6.41) | 2 (3.4) | 0.42 (0.08–2.08) | 10 (16.9) | 2.86 (0.98–8.34) | — | — | ||||||
Haplotypes | ||||||||||||||||
I | — | 1 | — | — | 1 | — | — | 1 | — | — | 1 | — | — | — | — | |
II | — | NA | NA | — | 0.33 (0.04–2.61) | 0.29 | — | — | — | — | 0.46 (0.06–3.72) | 0.47 | — | — | — | |
III | — | 0.39 (0.08–1.81) | 0.23 | — | 1.54 (0.61–3.88) | 0.36 | — | 0.45 (0.10–2.06) | 0.30 | — | 1.57 (0.56–4.38) | 0.39 | — | — | — | |
VII | — | 1.27 (0.48–3.38) | 0.63 | — | 2.5 (1.08–5.81) | 0.03 | — | 0.93 (0.32–2.72) | 0.89 | — | 1.98 (0.76–5.13) | 0.60 | — | — | — | |
End of treatment | ||||||||||||||||
UGT1A1 | *28/*28 | 6 (40) | 2.77 (0.91–8.47) | 0.065 | 10 (66.7) | 3.83 (1.23–11–86) | 0.014 | 6 (40) | 2.91 (0.95–8.92) | 0.05 | 9 (60) | 4.08 (1.36–12.28) | 0.008 | 5 (33.3) | 12.7 (3.14–51.34) | <0.0001 |
Other | 26 (19.4) | 1 | 46 (34.3) | 1 | 25 (18.7) | 1 | 36 (26.9) | 1 | 5 (3.8) | 1 | ||||||
UGT1A9 | *1/*1 | 10 (17.5) | 1 | 0.36 | 29 (50.9) | 1 | 0.008 | 10 (17.5) | 1 | 0.44 | 24 (42.1) | 1 | 0.013 | 5 (8.9) | 1 | 0.4 |
Other | 22 (23.9) | 1.48 (0.64–3.4) | 27 (29.3) | 0.4 (0.2–0.8) | 21 (22.8) | 1.39 (0.6–3.2) | 21 (22.8) | 0.41 (0.2–0.8) | 5 (5.5) | 0.6 (0.16–2.15) | ||||||
UGT1A7 | *3/*3 | 5 (22.7) | 1.09 (0.37–3.22) | 0.88 | 12 (54.5) | 2.26 (0.91–5.65) | 0.075 | 5 (22.7) | 1.14 (0.39–3.39) | 0.81 | 11 (50) | 2.74 (1.09–6.89) | 0.028 | 4 (18.2) | 4.41 (1.13–17.15) | 0.022 |
Other | 27 (21.3) | 1 | 44 (34.6) | 1 | 26 (20.5) | 1 | 34 (26.8) | 1 | 6 (4.8) | 1 | ||||||
All UGTs | No favourable* | 5 (45.5) | 3.4 (0.97–12.1) | 0.044 | 8 (72.7) | 5 (1.27–19.72) | 0.02 | 5 (45.5) | 3.59 (1.02–12.67) | 0.036 | 7 (63.6) | 4.61 (1.28–16–63) | 0.018 | 4 (36.4) | 12.38 (2.83–54.18) | <0.0001 |
Favourable | 27 (19.6) | 1 | 48 (34.8) | 1 | 26 (18.8) | 1 | 38 (27.5) | 1 | 6 (4.4) | 1 | ||||||
All UGTs | Favourable | 21 (21.3) | 1 | 0.5 | 26 (28.9) | 1 | 0.007 | 20 (22.2) | 1 | 0.6 | 20 (22.2) | 1 | 0.009 | 4 (4.5) | 1 | 0.19 |
Other | 11 (18.6) | 0.75 (0.33–1.71) | 30 (50.8) | 2.55 (1.29–5.05) | 11 (18.6) | 0.8 (0.35–1.83) | 25 (42.4) | 2.57 (1.26–5.27) | 6 (10.3) | 2.45 (0.66–9.1) | ||||||
Haplotypes | ||||||||||||||||
I | — | 1 | — | — | 1 | — | — | 1 | — | — | 1 | — | — | 1 | ||
II | — | 0.16 (0.02–1.24) | 0.08 | — | 1.29 (0.53–3.16) | 0.58 | — | 0.16 (0.02–1.24) | 0.08 | — | 1.27 80.48–3.32) | 0.63 | — | |||
III | — | 0.58 (0.23–1.43) | 0.24 | — | 1.58 (0.81–3.11) | 0.18 | — | 0.55 (0.22–1.36) | 0.2 | — | 1.31 (0.63–2.71) | 0.47 | — | |||
VII | — | 1.50 (0.76–2.98) | 0.25 | — | 2.11 (1.12–3.98) | 0.02 | — | 1.52 (0.76–3.03) | 0.23 | — | 2.24 (0.63–7.24) | 0.02 | — |
Abbreviations: CI=confidence interval; NA=not applicable; OR=odds ratio;
Note: All reported P-values correspond to χ2-test or Fisher's exact test, when appropriate.
No favourable UGT1A genotypes=UGT1A1*28/*28, UGT1A7*3/*3 and UGT1A9*1/*1.